Clinical Trial Update: The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating skin pigmentation changes near the eye in glaucoma patients treated with Xalatan, Travatan, or Lumigan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Lumigan (bimatoprost)
• Travatan (travoprost)
• Xalatan (latanoprost)

Snippet

Sponsor: Summa Health System | Conditions: Glaucoma, Application Site Pigmentation Changes | Phase 4 | Status: COMPLETED | Results posted: 2016-01-18